D

M

DEBRAY , Marie-Pierre

Last name: DEBRAY

First name: Marie-Pierre

April 25, 2018 (v1)

Journal article

Metadata-only

Rituximab for auto-immune alveolar proteinosis, a real life cohort study

Soyez, Berenice Borie, Raphael Menard, Cedric

Background: Whole lung lavage is the current standard therapy for pulmonary alveolar proteinosis (PAP) that is characterized by the alveolar accumulation of surfactant. Rituximab showed promising results in auto-immune PAP (aPAP) related to anti-GM-CSF antibody.Methods: We aimed to assess efficacy of rituximab in aPAP in real life and all...

Uploaded on: December 4, 2022
May 25, 2023 (v1)

Journal article

Metadata-only

Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial

Mankikian, Julie Caille, Agnès Reynaud-Gaubert, Martine

Background Standard of care for interstitial lung disease (ILD) with a nonspecific interstitial pneumonia (NSIP) pattern proposes mycophenolate mofetil (MMF) as one of the first step therapies while rituximab is used as rescue therapy. Methods In a randomised, double blind, two-parallel group, placebo-controlled trial ( NCT02990286 ), patients...

Uploaded on: June 3, 2023